A Partnership
of Excellence
The Leader in Prevention
Merck Animal Health is the trusted leader and advocate for disease prevention. From disease research and clinical studies, to the proven efficacy of NobivacĀ® vaccines, Merck Animal Health is always striving to help you keep pets safe.
A History of NobivacĀ®
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc egestas tempus felis, et fringilla ligula venenatis sed. Suspendisse dapibus scelerisque malesuada. In porta condimentum velit quis egestas.
1998
First company to develop a feline Bb vaccine with NobivacĀ® Feline-Bb
2003
First to introduce Advanced Delivery Technology (ADT) needleless vaccine delivery to avoid accidental injection of intranasal canine cough vaccinesāNobivacĀ® Intra-TracĀ® 3 ADT
2005
First USDA-approved canine distemper, adenovirus (Hepatitis), parvovirus (DAP) vaccine with 3-year DOIāNobivacĀ® Canine 3-DAPv
2006
First USDA-approved feline rhinotracheitis, calicivirus and panleukopenia virus (HCP) vaccine with a 3-year DOIāNobivacĀ® Feline 3-HCP
2008
Published first data demonstrating protection with our canine range against parvovirus 2c strain
2009
First to develop a Lyme vaccine, NobivacĀ® Lyme, that induced borreliacidal antibodies to outer surface protein C
First canine influenza (H3N8) vaccine with NobivacĀ® Canine Flu H3N8
2010
First company to provide a FeLV vaccine with a 2-year DOI with NobivacĀ® Feline 2-FeLV
2011
First leptospirosis vaccine, NobivacĀ® Lepto4, with label claims against mortality and urinary shedding caused by serovars L. canicola, L. grippotyphosa, L. icterohaemorrhagiae and L. pomona
Introduced VacciPure⢠filtration advancement to Nobivac® Lepto4
2016
Launched first bivalent canine influenza vaccine protecting against both CIV H3N2 and CIV H3N8 with NobivacĀ® Canine Flu Bivalent
2018
First canine influenza vaccine to include protection for felines
2019
Introduced first low-volume range of vaccines, which includes parainfluenzaāNobivac EDGEĀ® DAPPv, Nobivac EDGEĀ® Lepto4 and Nobivac EDGEĀ® DAPPv+L4
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
View More NobivacĀ® ResourcesReferences
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global